We are passionate about advancing innovation to deliver better treatment options. Our clinical research demonstrates the value of our technology and paves the way for future treatments to improve patient care.
The Recover-AV Trial is a Prospective, Multicenter, Multinational Study Evaluating the Effectiveness and Safety of the Alphavac Multipurpose Mechanical Aspiration (MMA) F1885 System for the Treatment of Acute Intermediate Risk Pulmonary Embolism (PE).
Ambition BTK is a Randomized Controlled Trial of the Auryon Atherectomy System Used in Combination with Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone in Treating Infrapopliteal Lesions in Subjects with Critical Limb Ischemia Below-The-Knee.
The APEX-Return study is intended to evaluate the safety and effectiveness of the AlphaReturn Blood Management System when used in conjunction with the cleared AlphaVac MMA System for the treatment of acute pulmonary embolism.
Pivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population
Investigational Study to Assess the Performance of the AlphaVac F1885 System in the Treatment of Pulmonary Embolism (PE)
A Clinical Study That Evaluates the Effects of Irreversible Electroporation (IRE) Ablation Technology on the Treatment of Patients with Stage III Pancreatic Cancer
Post-Market Registry of Auryon Atherectomy System in Subjects Affected with Infrainguinal Peripheral Artery Disease
Partnerships in Clinical Trial Engagements
Our grant opportunity that encourages clinical trial sites to build partnerships within underserved communities to increase participation in clinical research.
External Studies
Acute procedural and long-term outcomes after Below The Knee intervention with the Auryon Laser: Intravascular Ultrasound Findings
Immunomodulatory effects following focal ablation of localized prostate cancer with Irreversible Electroporation
A single-site feasibility trial for 42 subjects with favorable intermediate risk prostate cancer who undergo Irreversible Electroporation (IRE) followed by Magnetic Resonance guided Radiotherapy MRgRT
A randomized controlled trial comparing focal treatment with Irreversible Electroporation to radical treatment in localized prostate cancer
A randomized, multicenter, controlled, unblinded study in unresectable Stage 3 pancreatic adenocarcinoma utilizing NanoKnife System for Irreversible Electroporation
A Multi-Center, International Registry to evaluate the treatment of Prostate Cancer in terms of Recurrence, Functional outcomes and Safety
A Multi-Center Randomized Single-Blind Two Arm Intervention Study Evaluating Irreversible Electroporation for the Ablation of Prostate Cancer
Americas Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
NanoKnife, Auryon, and AlphaVac are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or subsidiary.